Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
38.7M
-
Shares change
-
-638K
-
Total reported value, excl. options
-
$865M
-
Value change
-
-$13.2M
-
Number of buys
-
89
-
Number of sells
-
-79
-
Price
-
$22.35
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q3 2023
197 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q3 2023.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.7M shares
.
Largest 10 shareholders include BlackRock Inc. (6.24M shares), Rubric Capital Management LP (3.18M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.63M shares), VANGUARD GROUP INC (2.34M shares), PRINCIPAL FINANCIAL GROUP INC (1.58M shares), Pacer Advisors, Inc. (1.29M shares), STATE STREET CORP (1.29M shares), RENAISSANCE TECHNOLOGIES LLC (1.17M shares), Invesco Ltd. (1.16M shares), and Camber Capital Management LP (1.05M shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.